# Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients

> **NCT00848562** · NA · COMPLETED · sponsor: **Toujinkai Hospital** · enrollment: 129 (actual)

## Conditions studied

- Acute Myocardial Infarction
- Congestive Heart Failure

## Interventions

- **DRUG:** Nicorandil

## Key facts

- **NCT ID:** NCT00848562
- **Lead sponsor:** Toujinkai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2009-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00848562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00848562, "Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00848562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*